Safety of Curcuma aromatica oil gelatin microspheres administered via hepatic artery

World Journal of Gastroenterology

Volumn 10, Issue 18, 2004, Pages 2637-2642

  Deng, Shi Gui ^a   Wu, Zhi Feng ^a   Li, Wei Ying ^a   Yang, Zhi Gang ^a   Chang, Gang ^a   Meng, Fan Zhe ^a   Mo, Li Li ^a  

^a GUANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMA AROMATICA EXTRACT; MICROSPHERE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CURCUMA AROMATICA; DOG; DOSE RESPONSE; DRUG SAFETY; HEPATIC ARTERY; HISTOPATHOLOGY; LETHAL DOSE; LIVER CANCER; LIVER INJURY; MEDICINAL PLANT; NONHUMAN; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 4544228724     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i18.2637     Document Type: Article

References (37)

1. Wang Y, Wang MZ. Study on the quality of Rhizoma Curcuma. Yaoxue Xuebao 2001; 36: 849-853
2. Li AQ, Hu XJ, Deng YH, Yao CS, Wang SJ, Chen JM. The chemical constituents of the volatile oil of Curcuma Wenyujin Y. H. Chen et C. Ling. Zhongcaoyao 2001; 33: 782-783
3. Huang KX, Tao ZM, Zhang AJ, Peng SL, Ding LS. Studies on chemical constituents of Curcuma aromatica salob. Zhongguo Zhongyao Zazhi 2000; 25: 163-165
4. Guo YT, Chu XK, Chen YR, Wu XY, Chen G, Lu XR. Studies on constituents of wenezhu (Curcuma aromatica Salise). Yaoxue Xuebao 1980; 15: 251-252
5. Yang SD, Chen YH. The determination of curcumol in the volatile oil of Curcuma aromatica by phloroglucinol spectrophotometry. Yaoxue Xuebao 1980; 15: 228-233
6. Yang S, Chen J, Chen Y. Determination of curcumol in the volatile oil of Curcuma aromatica. Yaoxue Xuebao 1979; 14: 356-361
7. Li CZ. Anti-inflammatory effect of the volatile oil from Curcuma aromatica. Zhongyao Tongbao 1985; 10: 38-40
8. Fu NW. Antitumor effect and pharmacological actions of beta-elemene isolated from the rhizome of Curcuma aromatica. Zhongyao Tongbao 1984; 9: 83-87
9. Zeng LL, Wang GY, Wang DX, Chen CH, Xu SY. Studies on the active ingredient of Curcuma aromatica Salisb and its effects. Yaoxue Xuebao 1982; 17: 946-950
10. Dai LM, Chen MZ, Xu SY. The therapeutic effect of the Chinese drug Yu-Jin (Curcuma aromatica salisb) on experimental allergic encephalomyelitis of the guinea pig. Yaoxue Xuebao 1982; 17: 692-695
11. Qian ZC, Liu JY, Zhao SR, Yu LH, Zhang DY, Wei WH. Prophylactic effect of active immunization with Curcuma aromatica treated tumor cells - exploration of mechanism of action of Curcuma aromatica. Yaoxue Xuebao 1981; 16: 892-896
12. Li GD, Xu F, Shen AJ. Research progress of Curcuma aromatica oil. Zhongguo Yaoxue Zazhi 2002; 37: 806-809
13. Tan M, Bin XN, Wu WY, Wang B, Zhang WB, Xiao CM. Effect of curcuma aromatica oil (CAO) on cellular apoptosis of hepatoma carried by mice. Zhongxiyi Jiehe Ganbing Zazhi 2002; 12: 290-291
14. Wang J, Wang SQ, Ni H, Chen L, Song WQ. Experimental studies in the inhibitory effects of Curcuma aromatica oil on human hepatic cancer cell line SMMC-7721 growth. Tianjin Zhongyiyao 2003; 20: 48-50
15. Shi LC, Wang B, Wu WY, Xiao CM, He QL. Study on molecule mechanism of inhibiting hepatoma of Curcuma aramatica oil in mice. Zhongyao Yaoli Yu Linchuang 2002; 18: 6-7
16. Shi LC, Wu WY, Zhang WB, Ou YQ, Tan M, Xiao CM. Effect of curcuma aromatica oil on proliferating cell nuclear antigen of hepatoma in mice. Shijie Huaren Xiaohua Zazhi 1999; 7: 156-157
17. Wu WY, Luo YJ, Cheng JH, Chang G, Xu Q, Liu WS, Li RX. Image cytometric DNA analysis of hepatic carcinomas carried by mice treaed by Curcuma aromatica oil (CAO). Zhongxiyi Jiehe Ganbing Zazhi 1999; 9: 18-20
18. Wu WY, Xu Q, Shi LC, Zhang WB. Inhibitory effects of Curcuma aromatica oil on proliferation of hepatoma in mice. World J Gastroenterol 2000; 6: 216-219
19. Wu W, Liu K, Tang X. Preliminary study on the antitumor immuno-protective mechanism of beta-elemene. Zhonghua Zhongliu Zazhi 1999; 21: 405-408
20. Li B, Liang N. Advances in the clinical application and experimental study of Curcurma zedoaria oil preparations. Zhongyaocai 2003; 26: 68-71
21. Han MJ, Ren K, Zhao ZC, Zhang XT. Oleum curcuma compound used in hepatic arterial embohzation to treat hepatocellular carcinoma: follow up report of 84 cases. Linchuang Fangshexue Zazhi 1998; 17: 112-114
22. Cheng JH, Chang G, Wu WY. A controlled clinical study between hepatic arterial infusion with embolized curcuma aromatic oil and chemical drugs in treating primary liver cancer. Zhongguo Zhongxiyi Jiehe Zazhi 2001; 21: 165-167
23. Chen CY, Xu K, Zhu DY, Wu WY, Deng H. Treatment of secondary hepatocarcinoma by hepatic artery perfusion embolism of oleum Curcumae: a clinical observation of 28 cases. Xinzhongyi 2003; 35: 23-24
24. Cheng JH, Wu WY, Liu WS, Chang G, Liu YL, Yang ZG. Therapeutic effect of Curcuma aromatica oil infused via hepatic artery against primary liver neoplasms: 17 cases. Shijie Huaren Xiaohua Zazhi 1999; 7: 92
25. Wu WY, Luo YJ, Cheng JH, Chang G, Liu WS, Li RX Therapeutic effect of Curcuma aramatica oil infused via hepatic artery against transplanted hepatoma in rats. Huaren Xiaohua Zazhi 1998; 6: 859-861
26. Deng R, Chen JM, Gao SC, Ding Y, Xu HD. Determination of Zedoary turmeric oil gelatin microspheres. Zhongguo Yiyuan Yaoxue Zazhi 2001; 21: 79-81
27. Deng R, Chen JM, Wu WY. The anti-tumor activity of Zedoary turmeric oil gelatin microspheres for heparical arterial embolization. Shenyang Yaoke Daxue Xuebao 2000; 17: 197-199
28. Wu WY, Deng R, Ou Y. Therapeutic efficacy of microsphere-entrapped curcuma aromatica oil infused via hepatic artery against transplanted hepatoma in rats. Zhonghua Ganzangbing Zazhi 2000; 8: 24-26
29. Deng R, Chen JM, Yao CS, Wu WY. Zedoary turmeric oil gelatin microspheres for hepatic arterial embolization. Yaoxue Xuebao 2000; 35: 539-543
30. Wu WY, Goo WJ, Chang G. Effect of CAO released from MS-CAO on human hepatoma cell line SMMC-7721. Shijie Huaren Xiaohua Zazhi 2003; 11: 260-263
31. Lindell B, Aronsen KF, Rothman U. Repeated arterial embolization of rat livers by degradable microspheres. Eur Surg Res 1977; 9: 347-356
32. Qian J, Feng GS, Vogl T. Combined interventional therapies of hepatocellular carcinoma. World J Gastroenterol 2003; 9: 1885-1891
33. Cheng JH, Liu LH. Advances in research of primary liver cancer treatment with Chinese herbal medicine embolization. Zhongguo Zhongxiyi Jiehe Zazhi 1997; 17: 187-190
34. Trinchet JC, Rached AA, Beaugrand M, Mathieu D, Chevret S, Chastang C. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332: 1256-1261
35. Li ZH, Li L, Yan LN, Lu WS, Xie XD, Luo YL. The side effect and its prevention of intra radioembolization using phosphorus-32 labelled glass microspheres for patients with nonresectable liver cancer. Huaxi Yixue 2002; 17: 29-32
36. Luo YK, Liang P, Dong BW, Yu XL, Su L. Selective puncture to embolize the portal vein with NBCA injection in rats: study on its efficacy and safety. Zhongguo Chaosheng Yixue Zazhi 2002; 18: 168-172
37. Li L, Yan LN, Chen XL, Wu YT, Sun WH, Li ML. The side effect and complication of intraarterial phosphorous -32 glass microspheres for patients with advanced hepatoma. Shengwu Yixue Gongchengxue Zazhi 1997; 14: 376-379